Fintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of West Pharmaceutical Services (NYSE:WST) with ...

Fintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of Bio-Techne (NasdaqGS:TECH) with a Outperform ...

Before GTC, hyperscale cloud customers said that Nvidia had an eight-year lead on the competition and that its "ecosystem is on a different continent," according to Evercore ISI analyst Mark Lipacis.

Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Argenx Se (ARGX – Research Report) yesterday and set a price target of ...

Evercore ISI analyst Glenn Schorr maintained a Buy rating on Goldman Sachs Group (GS – Research Report) yesterday and set a price target of ...

With over 100 legal challenges filed in response to executive actions taken by the Trump Administration, perhaps it was only ...

Evercore ISI sees Apple on track for double-digit earnings growth through 2029, driven by services, AI, and wearables ...

Nobody expects the Federal Open Market Committee to cut interest rates on Wednesday. That puts attention squarely on the ...

Investing.com -- Evercore ISI lifted its price target for Apple shares (NASDAQ: AAPL) to $275 from $260 in a note Tuesday, maintaining an Outperform rating on the stock. The firm emphasized the ...

The investment bank said Bio-Techne is a premium growth asset with a strong core business and growth verticals.

We recently published a list of 10 Stocks Market Experts are Talking About These Days. In this article, we are going to take ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea ...